| Metabolic syndrome: updates on pathophysiology and management in 2021 G Fahed, L Aoun, M Bou Zerdan, S Allam, M Bou Zerdan, Y Bouferraa, ... International journal of molecular sciences 23 (2), 786, 2022 | 675 | 2022 |
| Neurobrucellosis: brief review Y Bouferraa, MB Zerdan, R Hamouche, E Azar, C Afif, R Jabbour The neurologist 26 (6), 248-252, 2021 | 25 | 2021 |
| SO-30 Efficacy and safety of neoadjuvant short-course radiation followed by mFOLFOX-6 plus avelumab for locally-advanced rectal adenocarcinoma: Averectal study A Shamseddine, Y Zeidan, Y Bouferraa, R Turfa, J Kattan, D Mukherji, ... Annals of Oncology 32, S215, 2021 | 24 | 2021 |
| Management of colorectal cancer in the era of COVID-19: Challenges and suggestions W Alam, Y Bouferraa, Y Haibe, D Mukherji, A Shamseddine Science Progress 104 (2), 00368504211010626, 2021 | 19 | 2021 |
| The role of gut microbiota in overcoming resistance to checkpoint inhibitors in cancer patients: mechanisms and challenges Y Bouferraa, A Chedid, G Amhaz, A El Lakkiss, D Mukherji, S Temraz, ... International Journal of Molecular Sciences 22 (15), 8036, 2021 | 12 | 2021 |
| Metabolic factors affecting tumor immunogenicity: what is happening at the cellular level? R El Sayed, Y Haibe, G Amhaz, Y Bouferraa, A Shamseddine International Journal of Molecular Sciences 22 (4), 2142, 2021 | 11 | 2021 |
| Pathophysiology, clinical findings, and management of Fox‐Fordyce disease: A systematic review A Salloum, Y Bouferraa, N Bazzi, M Bou Zerdan, J Abi Chebl, T Chu, ... Journal of Cosmetic Dermatology 21 (2), 482-500, 2022 | 10 | 2022 |
| The impact of young age (< 40 years) on the outcome of a cohort of patients with primary non-metastatic breast cancer: analysis of 10-year survival of a prospective study Y Bouferraa, Y Haibe, A Chedid, E Jabra, M Charafeddine, S Temraz, ... BMC cancer 22, 1-12, 2022 | 9 | 2022 |
| Systemic AL amyloidosis: current approach and future direction MB Zerdan, L Nasr, F Khalid, S Allam, Y Bouferraa, S Batool, M Tayyeb, ... Oncotarget 14, 384, 2023 | 8 | 2023 |
| The gut microbiome and alzheimer’s disease: A growing relationship M Bou Zerdan, E Hebbo, A Hijazi, M El Gemayel, J Nasr, D Nasr, M Yaghi, ... Current Alzheimer Research 19 (12), 808-818, 2022 | 6 | 2022 |
| Results from the Survey of Antibiotic Resistance (SOAR) 2015–17 in the Middle East (Kuwait, Lebanon and Saudi Arabia): data based on CLSI, EUCAST (dose-specific) and … D Torumkuney, E Mokaddas, A Jiman-Fatani, A Ageel, Z Daoud, ... Journal of Antimicrobial Chemotherapy 75 (Supplement_1), i60-i75, 2020 | 6 | 2020 |
| A phase II single arm study of Nivolumab with stereotactic Ablative radiation Therapy after induction chemotherapy in CHOlangiocarcinoma (NATCHO) C Elias, YH Zeidan, Y Bouferraa, D Mukherji, S Temraz, M Charafeddine, ... BMC cancer 22 (1), 1296, 2022 | 4 | 2022 |
| Single cell RNA sequencing: A new frontier in pancreatic ductal adenocarcinoma M Bou Zerdan, M Shatila, D Sarwal, Y Bouferraa, M Bou Zerdan, S Allam, ... Cancers 14 (19), 4589, 2022 | 3 | 2022 |
| Complete radiological response of recurrent metastatic adrenocortical carcinoma to pembrolizumab and mitotane W Alam, Y Bouferraa, Y Haibe, A Shamseddine Clinical Medicine Insights: Oncology 15, 11795549211007682, 2021 | 3 | 2021 |
| Microbial influences on immune checkpoint inhibitor response in melanoma: the interplay between skin and gut microbiota Y Bouferraa, C Fares, M Bou Zerdan, L Boyce Kennedy International Journal of Molecular Sciences 24 (11), 9702, 2023 | 2 | 2023 |
| Total neoadjuvant therapy in patients with locally advanced rectal cancer: A tertiary medical center experience Z El Husseini, Y Haibe, Y Bouferraa, M Kreidieh, M Al Darazi, D Mukherji, ... Molecular and Clinical Oncology 15 (4), 1-6, 2021 | 2 | 2021 |
| Everolimus in poorly differentiated neuroendocrine carcinoma of unknown primary: A case report M Bou Zerdan, R Hamouche, Y Bouferraa, C Chouairy, D Gholam SAGE Open Medical Case Reports 10, 2050313X221106987, 2022 | 1 | 2022 |
| From Tumor Cells to Endothelium and Gut Microbiome: A Complex Interaction Favoring the Metastasis Cascade AH Abdel Sater, Y Bouferraa, G Amhaz, Y Haibe, AE Lakkiss, ... Frontiers in Oncology 12, 804983, 2022 | 1 | 2022 |
| Comparison Between Liver Stiffness Measurement by Fibroscan and Splenic Volume Index as NonInvasive Tools for the Early Detection of Oxaliplatin-induced Hepatotoxicity Y Bouferraa, Y Haibe, E Jabra, M Charafeddine, M Kreidieh, R Raad, ... Journal of Clinical and Experimental Hepatology 12 (2), 448-453, 2022 | 1 | 2022 |
| Insights of Medical Students and Graduates Toward Electronic Learning During the COVID-19 Pandemic in Lebanon: A National Cross-Sectional Study M Bou Zerdan, Y Bouferraa, M Bou Zerdan, J Al Barathie, R Khoury Journal of Medical Education and Curricular Development 10, 23821205231209106, 2023 | | 2023 |
Ali ShamseddineProfessor of Hematology-Oncology, American University of Beirut Medical CenterVerified email at aub.edu.lb
